Response Oncology (Response Oncology) EBIT : $-51.1 Mil (TTM As of Mar. 2002)

Response Oncology EBIT Chart

Response Oncology Annual Data
	Trend	Dec92	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01
EBIT		Get a 7-Day Free Trial					10.50	5.90	2.48	-17.40	-51.31

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
EBIT	Get a 7-Day Free Trial															-0.83	-0.27	-0.14	-50.07	-0.61

Competitive Comparison of Response Oncology's EBIT

For the Medical Care Facilities subindustry, Response Oncology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Oncology's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Response Oncology's EV-to-EBIT falls into.

Response Oncology EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-51.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Oncology  (GREY:ROIX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Response Oncology's annualized ROC % for the quarter that ended in Mar. 2002 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2002) data.

2. Joel Greenblatt's definition of Return on Capital:

Response Oncology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2002 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2002) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Response Oncology's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Oncology EBIT Related Terms

Thank you for viewing the detailed overview of Response Oncology's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description